Introduction
Endometriosis, defined by the presence of viable endometrial tissue outside the uterine cavity, is a common condition among women of reproductive age. Over the past 70 years, at least a dozen theories have been proposed to explain the histogenesis and aetiology of endometriosis. None of the theories alone can explain the entire spectrum and anatomical distribution of the lesions. It appears that the aetiology is multifactorial, and today a composite theory of retrograde menstruation with implantation of endometrial fragments in conjunction with peritoneal factors to stimulate cell growth is the most widely accepted explanation for peritoneal endometriosis (Olive and Schwartz, 1993) .
The association of endometriosis with infertility has long been noted. It is estimated that 25-50% of infertile women have endometriosis and, among women with endometriosis, 3&50% are infertile (Strathy et al., 1982) . In addition to infertility, endometriosis may also cause severe pelvic pain. Dysmenorrhoea, dyspareunia, back and rectal pain are common complaints in women with endometriosis. Investigators have attempted to identify the factors present in the peritoneal environment of patients with endometriosis that may help explain the pathogenesis of endometriosis and the pathophysiology of associated symptoms such as infertility and pain. Many have proposed that patients with endometriosis have an altered peritoneal environment that affects the presenting symptoms of the disease (Halme et al., 1987; Syrop and Halme, 1987a) . On the other hand, recently, there has been failure to demonstrate any association between concentrations of cytolunes and symptoms or severity of disease (Overton et al., 1996) . In this article,
Characteristics of peritoneal fluid
we review the current understanding ofthe peritoneal environment in patients with endometriosis as well as its poten-
Peritoneal fluid volume
tial role in the development ofthe disease and its associated pathologies.
PF is an ultrafiltrate of plasma. The peritoneal cavity ofthe human usually contains 5-20 ml of' serous straw-coloured tluid which varies widely depending on the physiological condition. In the female, this volume changes during the
Peritoneal fluid in endometriosis
The local environment that surrounds the endometriotic implant in the peritoneal cavity is quite dynamic. Peritoneum is the most extensive serous membrane in the body. The surface area of the peritoneum is generally equal to that of the skin (diZerega and Rodgers, 1992) . It consists of two layers: a loose connective tissue layer that contains collagen, elastic fibres, fat cells and macrophages and a mesothelial layer that consists of squamous cells. The peritoneal fluid (PF) arises primarily from two different sources: plasma transudate and ovarian exudate; other sources are tubal tluid, retrograde menstruation and macrophage secretions. Fallopian tubes and ovaries are bathed in PF. Oocytes are exposed to the peritoneal environment even after they are captured by the fimbria because the Fallopian tube is a conduit freely communicating with the peritoneal cavity. Spermatozoa are exposed to PF factors in the Fallopian tube before and during fertilization. The embryo undergoes early development in the Fallopian tube. where it is also potentially exposed to cellular and soluble components of PF. There is evidence suggesting that at least some of the uterine tluid may be of peritoneal origin (Casslen. 1986) .
The role of endometriosis-associated inflammatory changes in the local peritoneal environment has been receiving increasing attention. Changes in tluid volume as well as concentration of a variety of cells, hormones and other compounds have been characterized during normal menstrual cycles and in women with endometriosis (Syrop and Halme, 1987b) . Cellular and biochemical constituents of the PF have been suggested to play an important role in the pathogenesis of endometriosis (Halme et d . . 1988; Koutsilieris et ul., 199 I) .
PF is an immunologically dynamic environment that links the reproductive and immune systems. The abnormalities of PF seen in patients with endometriosis may also be linked to endometriosis-associated infertility. PF components may adversely interact with ovulatory function, gamete transport or survival, spermatozoon-ovum interaction, early embryonic development and implantation. PF has been shown to affect negatively ovum capture by the fimbria, sperm survival, spermatozoon-oocyte interaction and embryonic development (Ramey and Archer. 1993) . menstrual cycle to reach a maximum level after ovulation. PF volume depends on follicular activity. corpus luteum vascularity and hormone production (Syrop and Hal me. 1987b) . Endometriosis may alter PF volume by increasing fluid production by altering mesothelial permeability o r increasing colloid osmotic pressure a h a result of' altered protein content. A recent review assessed results from I7 studies that used different times of collection during the menstrual cycle (Hurst and Rock. 199 I 1. Five of those I7 studies showed increased volume in endometriosis. and I I showed no change. The largest 01' these suggested increased PF volume in endometriosis throughout the menstrual cycle (Syrop and Halme. I9X7b) . Howcver. two well-designed studies of PF in endometriosis. performed between cycle days 8-1 2 and cycle days 13-1 8, I'ailed to show an increase in PF volume among patients with endometriosis (Rock rt d . , 1982: Rezai ct til.. 19x7 ). Cycle day variations, improperly selected control groups and di1'-ferent collection techniques may explain the discrcpancics found in most of these studies. Syrop and Halme (1986) attempted to determine thc impact of PF volume on endometriosis-associated infertility. Women who achieved a pregnancy had a significantly lower PF volume than those who did not achieve pregnancy. Thus, PF volume was inversely related to the subscquent pregnancy rate in patients with endometriosis. In addition, Haney and Weinberg (1988) found that the \:OIL ume of PF decreased in every woman with endometrioxi\ after treatment with medroxyprogesterone acetate.
Overall, there are suggestive findings that the volume 01' PF in patients with endometriosis may be modestl!, increased, but this appears to be of little clinical importance and correlates poorly with infertility. Even if' the increase i n PF volume is proved. its role as a cause-and-cflect link between endometriosis and infertility is debarable, ;IS higher volumes are also present i n women with unexplained infertility.
histological morphology to identify cell types in PF, and found that women with early stages of endometriosis had the most pronounced increases of total leukocytes, macrophages, helper T lymphocytes and natural killer cells compared to fertile controls. These findings support an active immunological process. There is compelling evidence for increased white blood cell populations in the PF of women with endometriosis as compared to women without endometriosis. These cells may be chemotactically attracted to the peritoneal cavity in response to the disease, or their increased presence could represent the primary abnormality.
Macrophage

MCP-1
Macrophages
Fibrosis A Angiogenesis
Macrophages are attracted to the peritoneal environment more abundantly than any other cell type. These cells originate in the bone marrow, circulate as monocytes, and then migrate to various body cavities where they function primarily as phagocytes when activated. Macrophage-di--thelia1
Fibroblasts
Cells rected host defence mechanisms resulting in the recognition, phagocytosis, and destruction of micro-organisms are well known. hlacrophages digest and process peritoneal debris such as spermatozoa and endometrial tissue and present antigens to the T cells.
Macrophages are capable of secreting various substances, such as growth factors, cytokines, prostanoids, complement components and hydrolytic enzymes (Nathan, 1987) . Macrophages also promote cellular growth and viability through secretion of growth factors and cytokines. Furthermore, macrophages release low amounts of reactive oxygen metabolites, such as superoxide anion, hydrogen peroxide and singlet oxygen. Endometriosis produces a localized inflammatory response. Since the macrophage is the predominant nucleated cell in the PF, it probably represents the first-line host response to an inflammatory stimulus. Attracted by chemotaxis, these cells extravasate through small pores in the vessel wall and enter the peritoneal cavity to perform their phagocytic and secretory functions. Because of this, the association between macrophages and endometriosis has been investigated extensively (Figure 1) . Haney et al. (198 1) first reported an increase in peritoneal macrophages in infertile women with endometriosis. Subsequent studies of the PF of women with this disorder have confirmed an increased number, concentration and activation of macrophages (Olive et al., 1985; Dunselman et al., 1988) . Normally, PF contains leukocytes in concentration of 0.5-2.0 x 106/ml, of which 85% are macrophages (van Furth et al., 1979) . Their concentration appears to fluctuate during the menstrual cycle, being highest at the time of menstruation. Role of macrophages and macrophage mediators in the pathogenesis of endometriosis. EGF= epidermal growth factor; TGF = transforming growth factor; PDGF = platelet-derived growth factor; bFGF = basic fibroblast growth factor; IL = interleukin; TNF = tumour necrosis factor; MCP-1 = monocyte chemoattractant protein-I ; RANTES = regulated on activation normal T expressed and secreted.
The extent of endometriosis generally does not appear to be associated with macrophage count, although a tendency toward higher numbers has been observed in women with minimal to mild stages of disease (Olive et al., 1985) . Elevated numbers of macrophages in the peritoneal cavity of women with endometriosis may be the result of chronic stimulation by ectopic endometrial implants or due to excessive reflux of menstrual debris (Bartosik et al., 1986) . On the other hand, Haney et al. (1 99 1 ) have demonstrated that an inverse relationship exists between peritoneal inflammation and endometriosis, arguing against the chronic stimulation hypothesis. As the stage of endometriosis advances, the degree of peritoneal inflammation decreases.
A macrophage is activated before it becomes a phagocytic scavenger. Activation is manifested by several changes: increased activities of enzymes such as acid phosphatase, myeloperoxidase, leucine aminopeptidase, enhanced phagocytic ability and cellular enlargement. Several studies have examined the level of macrophage activation associated with endometriosis and infertility and have suggested that macrophage number and concentration may be less important than macrophage activation. Halme et al. (1983) showed that macrophages harvested from the peritoneal cavity of infertile women with endometriosis are larger and more activated (46 versus 15%) than macrophages from fertile women. Subsequent studies by this group confirmed an increased number of large, mature macrophages in the peritoneal cavity of women with endometriosis, with increased ability to phagocytose opsonized zymosan (Halme et d., I984a, 1987) .
These data also suggest that macrophages from patients with endometriosis are more differentiated than controls.
Macrophages can induce proliferation of cells. such as fibroblasts and endothelial cells, that are involved in inflammation, tissue repair and neovascularization through secretion of factors such as interleukin-I (IL-1 ), interleukin-6 (IL-6), tumour necrosis factor-a (TNFa). macrophage-derived growth factor (MDGF) and monocyte chemoattractant protein-1 (MCP-I). Studies have shown that increased amounts of these factors are associated with endometriosis (Fakih et al.. 1987; Halme et al., 1988 : Halme, 1989 .
Macrophage products may be responsible for growth or maintenance of ectopic endometrium. Surrey and Halme (1990) demonstrated that the PF from women with endometriosis stimulated cell proliferation in primary endometrial stromal cells in culture. Recently, using a unique co-culture system of immune cells and endometrial cells, significant differences between the effects of peripheral blood monocytes in women with and without endometriosis were observed (Braun et nl. , 1994) . Blood monocytes from patients with endometriosis enhance autologous endometrial cell proliferation, whereas blood monocytes from fertile patients suppress endometrial cell proliferation. Further support for this concept is demonstrated by studies showing that peritoneal macrophages from women with endometriosis produce substantially more fibronectin, a growth factor for fibroblasts, than macrophages from healthy women (Kauma et nl.. 1988) .
Increased numbers of macrophages in women with endometriosis and without mechanical infertility may also have an impact on oviductal transport of spermatozoa or their survival within the peritoneal compartment. Macrophage-mediated sperm phagocytosis has been noted quantitatively in the mouse (Olive et ul., 1987a) and the human (Muscat0 etal., 1982) . This concept is supported by the observation that ethiodiol, having been associated with increased fertility after hysterosalpingography, inhibits macrophage phagocytosis (Boyer et al. , 1986 , Johnson et al., 1992 .
On the basis of the data from studies on mice embryos (Umesaki et al., 1992) , peritoneal macrophages may also have an adverse effect on fertilization and embryonic development. These adverse effects may result from direct cell-mediated damage or from humoral factors derived from macrophages. Possible humoral factors include prostaglandins, cytokines and growth factors.
Endometrial cells
The histogenesis of endometriosis is classically explained by the endometrial implantation theory of Sampson ( 1 927) as being the consequence of retrograde seeding ofendometrial cells during menstruation. Initially, this theory was questioned because retrograde menstruation was thought to be a rare phenomenon. However. investigation has shown that retrograde menstruation is in fact quite c o nmon. Polishuk and Sharf ( 1965) , pertbrniing culdoscopy during the menstrual period, found blood-stained PF in 50% of the patients. Others have found that -90% of normal women experience retrograde menstruation, with 70'% exhibiting grossly bloody PF during menstruation (Halme et uf., 1984b) . However, the occurrence of red blood cells in PF during menstruation is not nece retrograde transport of viable endomelrial cells.
Studies analysing the incidence of endometrial cells in PF are conflicting; the incidence varying from 0 to 59% (Kruitwagen etal., 199 1 ) . Several investigators have found endometrial tissue in the PF of women with or without endometriosis with equal frequency (Koninckx r t (11.. 1980; Bartosik et al.. 1986) . Only one study has identified endometrial tissue more frequently in the PF of women with endometriosis (Badawy et al.. 19843 ). In addition. the incidence of endometriosis is high among women with excessive retrograde flow due to anomalies of Mullerianduct development with outflow obstruction (Olive and Henderson. 1987; Golan et ul., 1989) . These data suggest that retrograde transport of viable endometrial cells during menstruation occurs in most women with patent tubes. suggesting that another factor aside from the presence o f endometrial cell reflux is critical for the pathogenesis 01' endometriosis.
Mesothelial cells
The mesothelium, a simple squamous epithelium. lines the peritoneal cavity. It has been shown that human peritoneal cells are capable of producing haematopoietic growth factors, either constitutively (IL-1. IL-6. IL-8. MCP-I , granulocyte colony-stimulating factor. macrophage colony-stimulating factor) or in response to a variety of' stimuli, including TNFa. IL-I and epidermal growth factor (EGF) (Lanfrancone et nl.. 1992) . In addition, these cells secrete CA-125 from their apical surfaces (Zeillemaker ~t al., 1994) . These findings suggest that mesothelial cells play an important role in the regulation of peritoneal inflammation and tissue regeneration.
Lymphocytes (alterations in cell-mediated immunity)
An increased T-helper to T-suppressor ratio has been noted in PF samples from women with endometriosis, suggesting cellular immune activity in the peritoneal environment of these women . Significantly higher numbers of T cells and natural killer (NK) cells, but few B lymphocytes and no plasma cells have also been observed in the PF of women with endometriosis as compared to those without disease (Dmowski et al., 1994) . NK cells represent a cell population whose functional activities arise from the basic responsibility of safeguarding the biological system from foreign antigen invasion. The local NK-mediated cytotoxicity in PF might be important in pathogenesis of endometriosis by preventing implantation of regurgitated endometrial cells. Oosterlynck et al. ( 1 992) demonstrated significantly decreased NK activity of PF mononuclear cells in women with endometriosis. In PF of women with stage III-IV endometriosis, there was a significant decrease of NK cytotoxicity compared with those without endometriosis (Ho et al., 1995) .
It is interesting to note, however, that in endometriosis, despite decreased NK cell activity, the percentages of peripheral NK cells are unchanged (Oosterlynck et al., 199 1) or increased .
Why NK activily is decreased in the PF of women with endometriosis remains to be clarified. One possibility is that this effect is a result of soluble factors contained in the sera and PF of affected women. NK cell activity can be decreased in vitro by addition of sera or PF from women with endometriosis (Kanzaki et al., 1992) .
Soluble substances
Prostaglandins
Prostaglandins (PG) are the most extensively studied compounds in PF to date (Rock and Hurst, 1990) . There are several sources of PG in the peritoneal cavity, including macrophages, the peritoneal surface, ovarian follicles and endometriotic implants (Ylikorkala and Viinikka, 1983) . Due to their short half-life, physiologically active PG are infrequently measured; instead, prostaglandin metabolites have been studied: PGEM, PGFM, 6-ketoprostaglandin F1, (6-keto-PGF1,~) and thromboxane (TX)B2 have been measured as representatives of their active precursors PGE, PGFz,, PG12 and TXA2 respectively. Under physiological conditions, no significant cyclic variation of PG concentrations has been found (Syrop and Halme, 1987b) .
The accumulated data on PG in endometriosis remain hard to interpret. There are contradictory reports regarding levels of PGF2, and PGE2 in PF of women with or without endometriosis. Some of these have failed to show any difference (Chacho et al., 1986) , whereas others have found higher concentrations throughout the menstrual cycle (Badawy et al., 1985) or only in the secretory phase (De Leon et al., 1986) . Moon et al. (1981) documented the presence of PGF2, in ectopic endometrium. Drake et al. (1 98 1) measured stable metabolites ofTXA2 and prostacyclin in PF and observed an increase in patients with endometriosis compared with controls. They suggested that these mediators of smooth muscle contraction might cause infertility by altering tubal function. On the other hand, Badawy et al. (1982) and Dawood et al. ( 1 984) could not demonstrate cycle-dependent changes in the PF concentrations of PG, nor were there differences between patients with unexplained infertility and those with endometriosis. The concentration of 6-keto-PGF1 was elevated in patients with endometriosis, but no increase in total 6-keto-PGF1 was observed (Dawood et al., 1984) . In animal studies, moderate and severe endometriosis are associated with increased PF concentrations of PGFz,, with no change in PGE2 (Schenken et al., 1984) . Interestingly, PGF2, has also been implicated in endometrial cell proliferation (Orlicky et al., 1986) .
PG may also affect embryo implantation (Hahn et al., 1986) . A possible mechanism is increased uterine contractility with resultant expulsion of the embryo. Increased PF prostaglandins have been related to ovulation interference as well as to increase in tubal motility, such that the embryo arrives in the uterine cavity at a suboptimum time for implantation.
In summary, data on the amounts of TXB2, 6-keto-PGFI, and PGF2, in the PF of women with endometriosis are conflicting, but suggest that they may be raised. The question of whether these compounds can act as markers or even act as causal agents of reduced fertility is unknown.
Cytokines and growth factors
As discussed previously, macrophages in the peritoneal cavity release cytokines and growth factors in response to a variety of inflammatory stimuli. Cytokine activities are varied and include the following: proliferation and differentiation of immune cells; growth of connective tissue and endothelial cells; induction of release of hormones, enzymes and acute phase proteins; enhancement of various cytotoxic activities; regulation of immunoglobulin secretion and chemotaxis. Cytokines generally exert biological effects on a variety of cell types, i.e. they are pleiotropic. Additionally, cytokines may either induce or down-regulate the production of other cytokines.
It is now becoming evident that cytokines play an important role in reproduction at various levels, including gamete function, fertilization and embryo development, implantation and postimplantation survival of the conceptus. Furthermore, growth factors and inflammatory mediators produced by peritoneal leukocytes have recently been postulated to participate in the pathogenesis of endometriosis (Table I) . IL-I , IL-2, IL-6, IL-8 and TNFa are all increased in the PF of women with endometriosis, suggesting that these cytokines may be involved in the pathogenesis and pathophysiology of disease (Eisermann rt al.. 1988; Rier et al., 1994; Arici ef ul. 1996) . Khorram et a/.
( 1 993) aT = increased; ND = no difference. EGF = epidermal growth factor; TGFP = transforming growth factor p; IGF = insulin-like growth factor; PDGF = plateletderived growth factor; M-CSF = macrophage-colony stimulating factor; IL = interleukin; TNF = tumour necrosis factor; IFN = interferon; MCP-1 = monocyte chemoattractant protein-1 ; RANTES = regulated on activation normal T expressed and secreted.
Cytokines Interleukin-1 : The IL-1 system is composed of IL-I a (1 59 amino acids), IL-1 p ( I 53 amino acids) and an inhibitor, IL-I receptor antagonist ( 1 52 amino acids).
Although IL-1 a and IL-1 p are encoded by different genes and have different amino acid sequences, both are recognized by the same receptor on target cells and produce the same biological effects (Dower et al., 19x6) . Although some investigators could not observe a difference in IL-1 activity in the PF or in the in-vitro rate ot'production of IL-I between individuals with and without endometriosis (Awadalla et al.. 1987) , others have shown that it is raised i n endometriosis (Fakih et al., 1987) . IL-I induces prostaglandin synthesis, T-cell proliferation, and stimulation ot' B-lymphocyte immunoglobulin production. The increased level ofthis cytokine in the PF of patients with endonietriosis may have a stimulatory effect on fibroblast proliferation and collagen deposition, suggesting a role in the pathogenesis of adhesions and peritoneal fibrosis in endometriosis.
There are conflicting observations as to the effect of IL-1 on early reproductive events in vitro (Fakih et ul., 1987 : Hill et al., 1987a . IL-1 inhibits mouse embryo development in vitro (Fakih et al.. 19x7; Hill et al.. 1987b) . but only at very high concentrations (>IOh U/nil). IL-1 also impairs the oocyte penetrating capacity of the spermatozoon, both in the hamster and the human (Sueldo et al.. 1990 ). On rhc other hand. Hill et a]. ( 1987a) reported no significant effect of 1L-I on sperm motion parameters. I t has been demonstrated that IL-I and TNFa concentrations were markedly low in the PF from women who had undergone medicnl treatment for endometriosis as compared to women with untreated endometriosis. Finally, PF of women with treated endometriosis is much less embryotoxic than PF ol' women with untreated disease (Taketani et ai.. 1992) . Interlriikin-2: IL-1 stimulates IL-2 secretion by T cells. IL-2 was found to abrogate the deficient cytolytic and l y nphokine-activated killer cell activity in peripheral blood monocytes of endometriosis patients (Oosterlynck et al.. 1994~1) . However. IL-2 was not detectable in either PF 01-macrophage-conditioned media 01' women with endometriosis ( Keenan et al.. 1995) . This finding suggests that there is no obvious role of1L-2 in either the pathogencsis or pathophysiology of endometriosis. Intrrlrukin-6: IL-6 is a potent cytokine that has diversc effects, several of which are potentially related t o tissue repair, including stimulation of acute-phase reactant synthesis and angiogenesis (Le and Vilcek. 19x9) . IL-6 is sccreted by monocytes/niacrophages and has been noted to be raised in women with endometriosis (Buyalos et al.. 1991). Rier et al. (1995) have shown that the severity 01. endometriosis is correlated with the increased concentration of IL-6 accompanied by a decrease o f IL-h soluble receptor concentration in the PF. Irztrrlrukin-8: This cytokine is a chemoattractant for new trophils and a potent angiogenic factor. I t is produced by ;I number of cell types, including monocytes. endothelial cells, fibroblasts. mesothelial cells and endometrial stro-mal cells (Arici et al., 1993) . PF of women with endometriosis has been shown to have increased neutrophil chemotactic activity (Leiva et al., 1993) . Recently, it has been identified that IL-8 concentrations are higher in the PF of women with endometriosis than of controls. Furthermore, the IL-8 concentrations seem to be related to the stage of the disease (Ryan et al., 1995; Arici et al., 1996) . Tumour necrosis factor-a: The concentration of TNFa, another cytokine with a wide range of biological effects, is known to be increased in PF of women with endometriosis (Eisermann et al., 1988) . Human peritoneal macrophages have been noted to secrete TNFa in vitro, with those collected from women with endometriosis having the greatest production rate (Halme, 1989) . TNFa also enhances the adhesion of endometrial stromal cells to mesothelial cells when included in the culture medium (Zhang et al., 1993) . TNFa has been linked to a variety of additional reproductive effects. It significantly affects sperm motility in vitro, but only at very high concentrations (Hill et al., 1987a) . In addition, Hill et al. ( I 987b) tested various concentrations of cytokines and found significant embryotoxicity only by TNFa and IFNy Interfclron-y: IFNy is toxic to a variety of virally infected and neoplastic cells and can interfere with cell growth by disrupting the structural organization of the plasma membrane cytoskeletal complex (Wang et al., 1981) . It also adversely affects sperm motility, fertilization, early embryonic development and trophoblast proliferation in vitro (Hill et al., 1987a,b; Berkowitz et al., 1988) . A local antiproliferative effect of IFNyis supported by the finding that IFNy inhibits in-vitro proliferation of endometrial epithelial cells (Tabibzadeh et al., 1988) . This cytokine also significantly inhibits blastocyst implantation in vitro (Haimovici et al., 1991) . This inhibition is observed at concentrations as low as IO3 U/ml. Hill et al. have demonstrated that TNFa and IFN-y adversely affect many reproductive processes including sperm motility (Hill et al., 1987a) , fertilization and embryo development (Hill et al., 1987b) . IFNy concentrations do not differ in the PF of women with or without endometriosis (Khorram et al., 1993; Keenan et al., 1994) .
Monocyte chemotactic protein-I:
This cytokme is a potent chemotactic and activating factor specific for monocytes. PF from patients with endometriosis has increased chemotactic activity for macrophages (Leiva et al., 1993) . We have previously shown that human endometrial tissue expresses MCP-1 (Arici et al., 1995a) . Recently, it has been shown that MCP-I secretion is up-regulated in cytokinestimulated endometrial cells of women having endometriosis as compared with normal women (Akoum et al., 1995) . We find that MCP-1 concentrations are raised in PF from women with endometriosis. In addition, amounts of MCP-1 were significantly higher in the PF from women who had untreated endometriosis than in that from women who had undergone medical treatment with gonadotrophin-releasing hormone analogue (A. Arici et al., unpublished results) . RANTES: RANTES is a newly discovered T-cell-specific cytokine of the platelet factor 4 gene superfamily (Schall, 1991) . RANTES is a selective chemoattractant for monocytes and T lymphocytes (Schall et al., 1990) . Recently, PF concentrations of RANTES have been found to be increased in women with endometriosis and concentrations are related to the severity of the disease (Khorram et al., The role of cytokines and growth factors in the pathophysiology of endometriosis-associated infertility is also actively under investigation. Peritoneal macrophages, through IL-1 secretion. may modulate human granulosaluteal cell progesterone production (Halme et al., 1985) . Hill et al. ( I 987b) tested various concentrations of IL-1, E-2, IFNy and TNFa and found significant embryotoxicity only by the latter two cytokines. Similarly, Schneider et ul. (1989) did not find that IL-1 and IL-2 exhibited embryotoxic effects. Thus, IFNyand TNFa remain the two cytokines found in the PF of patients with endometriosis consistently exhibiting gamete toxicity. Cytokine concentrations in PF from women with endometriosis have also been reported to be reduced after medical treatment (Taketani et al., 1992) . A reduction in embryotoxicity was associated with this drop in cytokine concentrations as determined by using mouse 2-cell embryos.
1993).
Growth,factors Platelet-derived growth factor: PDGF is a well-characterized secretory product of activated macrophages, playing a major role in the inflammatory response as a potent mitogen for fibroblast and angiogenic precursor cells. PDGF was previously identified in the PF of women with endometriosis (Halme et ai., 1988) . This was originally thought to be unique to the macrophage and was termed 'macrophage-derived growth factor'. Subsequently, some of this molecular activity was found to be identical to PDGF (Surrey and Halme, 1991) . PDGF has a significant dose-dependent proliferative effect on endometrial stromal and epithelial cells (Surrey and Halme, 1991) . Epidermal growthfactor: EGF acts as a mitogen for most epithelial cells. Its concentration in the PF is positively correlated with the day of the cycle. Highest concentrations are seen in the luteal phase (De Leon et al., 1986) . Ectopic endometrium is known to express oestrogen receptors (Prentice et al., 1992a) , and its growth and maintenance are dependent on continued stimulation by oestrogen. In recent years it has become apparent that oestrogen action in the endometrium may be mediated by the peptide growth factors, in particular EGF (Mellor and Thomas, 1994) . EGF exerts its effects through binding to its cell surface receptor, the EGF receptor. EGF receptors have been described in normal human endometrium by several investigators (Prentice et al., I992b) . It has been shown using immunohistochemistry that EGF receptor is expressed in the glands and stroma of eutopic and ectopic endometrium of women with endometriosis (Prentice et ai., 1992b) .
Macrophage-colony stimuluting fbctor (M-CSF):
This growth factor has been identified in the PF of women at consistently higher concentrations than in plasma (Weinberg et al., 1991) . Furthermore, the concentration of M-CSF was significantly higher in the patients with endometriosis than in those without endometriosis (Fukaya et al., 1994) . It is involved in the differentiation of monocytes to become phenotypically activated macrophages and can serve as a chemotactic factor for blood monocytes.
Trunsftirming growth juctor-p (TGFP):
Beside its growthregulating properties, TGFP is one of the most potent chemoattractants for human monocytes and is an inducer of fibrosis and angiogenesis, indicating that it is an important mediator of tissue repair. Furthermore, TGFP has striking immunological functions and can profoundly inhibit T lymphocyte, B lymphocyte and NK cell functions (Rook et al., 1986) . Increased TGFB activity in the PF of women with endometriosis has been demonstrated by Oosterlynck et al. ( I994b) . They suggested that the decreased NK activity of PF in women with endometriosis may be secondary to increased TGFP activity in PF. Insulin-like growth juctors: IGF-I and IGF-11 are mitogens that can also promote differentiation. The IGF circulate bound to IGF-binding proteins (IGFBP), which also regulate their actions at target tissues. Giudice et al. ( 1994) have shown that human PF contains IGF-I, IGF-11, IGFBP-I , -2, -3, and -4; and the IGFBP-3 protease. In addition, they demonstrated that IGF was mitogenic to endometrial stromal cells in a dose-dependent manner. The IGF system may be one of several growth factor systems in PF that has the capacity to stimulate endometrial cellular proliferation. Basic fibroblast growth fuctor: bFGF, a heparin-binding angiogenic protein, is highly mitogenic for capillary endothelial cells in vitro and can induce angiogenesis in vivo (Folkman and Klagsbrun, 1987) . Secretion of bFGF by endometrial cells increases in response to 17P-oestradiol and is inhibited by progesterone (Presta, 1988) . bFGF has been found in endometrial glandular epithelium and is a potent mitogen for endometrial stromal cells in culture (Irwin et ai., 1991) . bFGF may be one of several growth factors acting in a paracrine fashion that is contributing t o stromal proliferation. This growth factor has not been reported so far in the peritoneal environment of endometriosis patients.
An uncharacterized macrophage-derived growth factor has been described in an animal model which functions as a competence factor, allowing endometrial stromal cells to respond to mitogenic stimuli such as oestrogen (Olive or  ai., 1991) .
Angiogenic,firctors Angiogenic factors released from peritoneal macrophages may also play a role in the development of endometriosis. By now, several angiogenic agents have been purified, including bFGF. angiogenin, TGFa and TGFP, TNFa, EGF and IL-8 (Folkman and Klagsbrun, 1987) . PF of women with endometriosis displays greater angiogenic activity than PF obtained from women without the disease (Oosterlynck et d.. 1993) . Vascular endothelial growth factor (VEGF) is a potent angiogenic factor that is present in increased amounts in the PF 01' women with endometriosis (McLaren et 111.. 1996) . Also. the concentration of VEGF in the proliferative phase is significantly higher than in the secretory phase. These angiogenic factors in the PF of women with endometriosis could be produced by retrograde menstruation of endometrial cells or by the ectopic endometriotic lesions themselves. The growth of endometriosis requires an accessible blood supply. It could be postulated that the release ot' angiogenic factors into the peritoneal compartment produces an increased microvascularization of the parietal peritoneum.
CA-125
Endometrial cells express the antigen CA-125, an epitope that has been demonstrated to be associated with coelomic epithelium and its neoplastic derivatives. Since Barbieri ri ul. (1986) demonstrated raised serum concentrations of CA-I 25 in patients with advanced endometriosis. this marker has been suggested as a means of diagnosing or following the disease (Pittaway and Fayez, 1986) . Concentrations of CA-125 in PF are higher than in serum, but originally no significant difference was observed in the PF concentrations of CA-I25 of women with and without en- More recently, Barbati et a/. (1994) . using a two-step immunoradiometric assay, found concentrations of CA-125 in PF to be a more sensitive indicator of disease than those in serum. CA-125 is not likely to play a direct role in the pathophysiology of endometriosis. but serum concentrations may provide a useful indicator of the extent of disease or response to therapy. 
Effects of peritoneal fluid on reproductive events
On sperm survival
It is clear that macrophages are primarily responsible for physiological phagocytosis of cellular debris, including spermatozoa, in the pelvis (Olive et al., 1987a) . To date, only one study has shown increased sperm phagocytosis in PF of patients with infertility and endometriosis. In a landmark study, Muscato et al. (1982) demonstrated that peritoneal macrophages phagocytosed spermatozoa in vitro, and that macrophages from women with endometriosis were more active than those from women without disease. In patients with antisperm antibodies, increased numbers of macrophages could promote sperm phagocytosis (London et al., 1985) . Olive et al. (1985) suggested that this increase reflects the presence of infertility without a mechanical cause.
The issue of sperm toxicity in patients with endometriosis has been addressed by many investigators. Sperm motility (Curtis and Jackson, 1993; Drudy et al., 1994) , capacitation (Bielfeld et al., 1993) , acrosome reaction (Arumugam, 1994) and gamete interaction (Coddington et al., 1992) have been studied. A summary of the findings concerning sperm parameters is presented in Table 11 . Stone and Himsl (1986) inseminated patients just prior to laparoscopy and then collected cul-de-sac fluid. No difference in motile sperm count could be found between those with and without mild endometriosis. However, Burke (1 987) reported reduced sperm velocity in vitro when PF from patients with endometriosis was added to the medium. Oak et al. (1985) incubated normal spermatozoa in PF and found a significantly reduced proportion of motile spermatozoa in the presence of endometriosis when compared to controls. Using a computerized semen analysis system, Leach et al. (1990) did not find an effect of PF from patients with endometriosis on sperm velocity after up to 6 h of incubation.
On spermatozoon-oocyte interactions (fertilization)
Studies to evaluate the effect of PF on sperm penetration of oocytes revealed conflicting results. PF, in general, reduces fertilization of murine oocytes in vitro when added to the medium, but this effect is enhanced when the PF is from women with endometriosis (Sueldo et al., 1987) . When spermatozoa are exposed to macrophage-conditioned medium, a decrease in hamster egg penetration assay scores is noted (Chacho et a/., 1986) . Halme and Hall ( 1982) were unable to demonstrate any effect of PF from patients with endometriosis on penetration of rona-free hamster ova. 
On early embryonic development
The availability of murine embryos has made it possible to test the effect of PF or macrophage-conditioned media on the development of mouse embryos in vitro. Steinleitner et af. ( I 990a) found that PF from women with endometriosis injected i.p. into hamsters caused a decrease in oocyte recovery and embryo development. The causative agent proved to be heat labile. Similarly, Prough et ul. ( 1990) found that a heat-labile substance in the PF of women with endometriosis, obtained during follicular phase laparoscopy, inhibited growth of the 2-cell mouse embryo. In an elegant study by Steinleitner er a/. (1990b) . activated, deactivated and non-activated macrophages were injected into the peritoneal cavity of ovarian-stimulated mice about to mate. The number of oocytes and embryos recovered was depressed by activated macrophages, but this effect was not apparent with deactivated macrophages or macrophages in the basal state. It has been reported that PF from women with endometriosis induces decreased fertilization in the mouse model (Sueldo et a/. , 1987) and also causes 21 decrease in mouse embryo cleavage rate (Marcos et al., 198.5 The reason for these contradictory findings is unclear. and doubts have been raised about the lack of sensitivity of' the murine embryo model for predictins toxicity toward human embryos. In summary, PF trom patients with endometriosis has been demonstrated frequently to hc toxic to embryos ir? tlirro (Marcos cf ol.. 1985) and irr i Y i~) (Steinleitner et ul.. 1990a) (Table III) , but the underlying mechanism and clinical significance remain unknown.
Other studies
An unknown PF factor has been found to interfere wilh ovum capture (Suginami et af.. 1986) . Oocyte capture was significantly diminished by incubating the fimbria with native or cell-free PF of women with endometriosis. The source of this activity remains obscure. but the substance that diminishes oocyte capture is water soluble with a molecular size of> Io0 kDa. Danazol appears to decrease the amount 01' this substance in the PF of women with endometriosis.
PF oestrogen and progesterone concentrations are not ditferent in endometriosis when compared with controls in the proliferative or secretory phase (De Leon of ol.. 1986). Pt; total protein content i s unchanged by the presencc 01' endometriosis (Halme et a/., 1984a) . The activity ot' PF lysozyme. a ubiquitous product of macrophages, is not d in endometriosis when compared with controls (Olive rf ol.. 1987b). Halme and Mathur ( 1987) documented anti-endometrial antibodies in the PF of 22 patients and tound 0.96 specificity, 0.23 sensitivity. Complement components Cj(. and CJ, mediators of host response to intlammation. are also increased in the PF of patients with endometriosis (Badawy et til.. I984b) . Integrins, important cell adhesion molecules. are expressed in endometriotic lesions and in epithelial cells in PF ( Van der Linden et til.. 1994) . These cell adhesion molecules could be involved in the attachment of endometrial tissue fragments to the peritoneum after the shedding of' endometrial tissue during menstruation. PF of patients with minimal to moderate endometriosis demonstrates a signiticantly higher chemotactic activity for granulocytes than that of patients without endometriosis or with medical suppression (Leiva ('1 d., 1993) . The amounts and activity 01' numerous other compounds have been measured in PE bur concentrations of these compounds do not appear to hc raised in patients with endometriosis. They include fibronectin, plasminogen activator activity. substance P. cholesterol. inhibin and albumin (Kamey and Archer. 1093).
Conclusion
Endometriosis stands as one of the most investigated disorders of gynaecology, with >4.500 articles published on the subject in the past 25 years. Yet. despite this intense academic interest, there remain basic holes in our understanding of this enigmatic disease. The importance of understanding the peritoneal microenvironment in order to decipher the pathogenesis of endometriosis has long been recognized. However, it is still unknown whether the increased activity of peritoneal inflammatory cells and their mediators is due to the presence of endometriotic implants or whether the endometriosis is resulting from an occult systemic immune disease. There are two hypotheses: the ectopic endometrium incites an intraperitoneal inflammatory response, resulting in recruitment and differentiation of peritoneal macrophages; the alternative is the converse, that a primary disorder of macrophage number or function may contribute directly to ectopic endometrial growth.
Intense research conlinues to improve our understanding of the PF environment. This will enable us to offer better and more effective modes of treatment. Findings summarized above are compelling evidence suggesting that the PF in women with endometriosis is pro-inflammatory. While this fact is now widely accepted, investigators have remained divided on whether these changes precede the disease or follow endometriosis as a consequence. We have recently identified the presence of two pro-inflammatory chemoattractant cytokines for monocyte/macrophages (MCP-1) and for granulocytes in the PF. Concentrations of both IL-8 and MCP-1 are not only raised in PF of women with endometriosis compared to those without endometriosis, but are correlated with the severity of the disease. In the peritoneal cavity, several tissues can account for the increased concentrations of IL-8 and MCP-1. Aside from mesothelial cells, which form the majority of the cells in the peritoneal cavity, macrophages and endometrial cells themselves are potential sources of these chemoattractant cytokines. On the basis of these findings it is tempting to postulate that IL-8 and MCP-1 are mediators in the pathogenesis of endometriosis.
What role PF plays in the resulting infertility in patients with endometriosis remans to be clarified. Some existing data suggest that changes in the peritoneal environment may play an important part in the interruption of the process of normal folliculogenesis, ovulation, conception and implantation. Conflicting reports concerning adverse effects of PF on reproductive processes also exist; these differences may be due to variations in study design. Small sample size and inadequate controls have also contributed to this confusion.
The studies on PF characteristics, such as PF volume, macrophages and prostaglandins also have limitations. Cycle timing, control group selection and collection techniques have varied frorn one study to another, making it difficult to interpret the data. Cycle day at the time of recovery is rarely controlled, and such variation may have a profound effect. Selection of control groups has also been a major source of criticism.
In summary, the PF is a dynamic environment that links the reproductive and immune systems. It appears likely that endometriotic tissue is influenced by this environment, and in turn the PF is altered by the presence of endometriosis. The result is a cellular soup rich in stimuli ready to assist in the growth and maintenance of endometrial implants as well as inhibition of fertility. Macrophages appear to play a leading role in this drama, with contributions from other cell types such as peritoneal mesothelium, lymphocytes and even endometrium itself. Accumulated soluble substances such as prostaglandins, cytokines and growth factors probably act as mediators to induce both endometriotic support and interference with fertility/early embryonic development. To date, studies have been limited by inadequate methodology and a failure to test hypotheses a priori. Further basic research into the specific roles of these cells and soluble factors may offer the possibility of more effective prevention and treatment of endometriosis.
